CNTA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CNTA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.
Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.
Gregory M Weinhoff | officer: Chief Financial Officer | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FL., 1 ASHLEY RD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Saurabh Saha | director, officer: Chief Executive Officer | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Karen M. Anderson | officer: Chief People Officer | C/O MIMECAST LTD., 191 SPRING STREET, LEXINGTON MA 02421 |
Harris Rotman | officer: SVP Regulatory Affairs | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FL., 1 ASHLEY RD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Antoine Yver | officer: Chief Medical Officer | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Tia L Bush | officer: Chief Quality Officer | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
David J Grainger | officer: Chief Innovation Officer | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FL., 1 ASHLEY RD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Thomas Templeman | officer: Chief Technology Officer | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
David M Chao | officer: Chief Administrative Officer | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Iqbal J Hussain | officer: General Counsel | C/O CENTESSA PHARMACEUTICALS PLC, D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS, CAMBRIDGE X0 CB22 3FH |
Mathias Hukkelhoven | director | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FL., 1 ASHLEY RD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Javad Shahidi | officer: Chief Medical Officer | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Medicxi Ventures Management (jersey) Ltd | 10 percent owner | C/O INTERTRUST FUND SERVICES (JERSEY), 44 ESPLANADE, ST. HELIER Y9 JE4 9WG |
Rubertis Francesco De | director | C/O MEDICXI, COURS DE RIVE 10, GENEVA V8 CH-1204 |
Aaron Kantoff | director | C/O CENTESSA PHARMACEUTICALS PLC, D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS, CAMBRIDGE X0 CB22 3FH |
From GuruFocus
By Marketwired • 05-21-2024
By GlobeNewswire • 08-23-2023
By GlobeNewswire • 09-13-2024
By GuruFocus Research • 08-24-2024
By Marketwired • 04-23-2024
By Marketwired • 08-13-2024
By Marketwired • 04-24-2024
By Marketwired • 11-04-2024
By Marketwired • 05-13-2024
By GuruFocus Research • 03-27-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.